A carregar...
Asenapine Treatment in Pediatric Patients with Bipolar I Disorder or Schizophrenia: A Review
Asenapine, administered as a twice-daily (BID) sublingual tablet, is approved in the US as monotherapy for the acute treatment of manic and mixed episodes of bipolar I disorder in children and adolescents aged 10–17 years based on the positive results of one 3-week, double-blind, placebo-controlled...
Na minha lista:
| Publicado no: | Paediatr Drugs |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5856894/ https://ncbi.nlm.nih.gov/pubmed/29170943 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40272-017-0274-9 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|